|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
||
|
|
|
||
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Smaller reporting company
|
Emerging growth company
|
Page
|
||
PART 1 - FINANCIAL INFORMATION
|
||
Item 1.
|
||
1 | ||
2 | ||
3 | ||
5 | ||
6 | ||
Item 2.
|
25 | |
Item 3.
|
29 | |
Item 4.
|
29 | |
PART II - OTHER INFORMATION
|
||
Item 1.
|
30 | |
Item 1A.
|
30 | |
Item 2.
|
31 | |
Item 3.
|
31 | |
Item 4.
|
31 | |
Item 5.
|
31 |
|
Item 6.
|
32 | |
33 |
September 30, 2022
|
December 31, 2021
|
|||||||
(Unaudited)
|
|
|||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash
|
$
|
|
$
|
|
||||
Prepaid expenses and other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
Investments held in Trust Account
|
|
|
||||||
Total Assets
|
$
|
|
$
|
|
||||
LIABILITIES, REDEEMABLE CLASS A COMMON STOCK AND STOCKHOLDERS’ DEFICIT
|
||||||||
Current liabilities:
|
||||||||
Accounts payable and accrued expenses
|
$
|
|
$
|
|
||||
Franchise tax payable
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Warrant liabilities
|
|
|
||||||
Deferred underwriting fee payable
|
|
|
||||||
Total Liabilities
|
|
|
||||||
Commitments and Contingencies (Note 6)
|
||||||||
Class A common stock, $
|
|
|
||||||
Stockholders’ Deficit
|
||||||||
Preferred stock, $
|
|
|
||||||
Class A common stock, $
|
|
|
||||||
Class B common stock, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
Total Stockholders’ Deficit
|
(
|
)
|
(
|
)
|
||||
TOTAL LIABILITIES, REDEEMABLE CLASS A COMMON STOCK AND STOCKHOLDERS’ DEFICIT
|
$
|
|
$
|
|
For the Three Months Ended September 30, 2022
|
For the Three Months Ended September 30, 2021 | For the Nine Months Ended September 30, 2022 |
For the Period from March 1, 2021
(inception) Through September 30, 2021
|
|||||||||||||
Formation and operating costs
|
$
|
|
$
|
|
$ |
$
|
|
|||||||||
Franchise tax | ||||||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other income (expense) |
||||||||||||||||
Expensed offering costs
|
( |
) | ( |
) | ||||||||||||
Realized gain on investments held in Trust Account
|
||||||||||||||||
Unrealized gain on investments held in Trust Account
|
||||||||||||||||
Gain from change in fair value of warrant liabilities
|
||||||||||||||||
Total other income, net |
||||||||||||||||
Net income
|
$
|
|
$ | $ |
$
|
|
||||||||||
Weighted average shares outstanding, Class A common stock subject to possible redemption
|
|
|
||||||||||||||
Basic and diluted net income per share, Class A common stock subject to possible redemption
|
$
|
|
$ | $ |
$
|
|
||||||||||
Weighted average shares outstanding, Class B common stock(1) | ||||||||||||||||
Basic and diluted net income (loss) per share, Class B common stock | $ | $ | ( |
) | $ | $ | ( |
) |
For the Nine Months Ended September 30, 2022 | ||||||||||||||||||||||||||||
Class A Common Stock
|
Class B Common Stock
|
Additional |
Total
|
|||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Paid-in
Capital
|
Accumulated Deficit
|
Stockholders’
Deficit
|
||||||||||||||||||||||
Balance as of December 31, 2021
|
|
$
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of March 31, 2022
|
—
|
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Net income
|
—
|
|
—
|
|
|
|
|
|||||||||||||||||||||
Balance as of March 31, 2022
|
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of June 30, 2022
|
— |
— |
( |
) | ( |
) | ||||||||||||||||||||||
Net income
|
—
|
|
—
|
|
|
|
|
|||||||||||||||||||||
Balance as of June 30, 2022
|
|
$
|
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of September 30, 2022
|
— | — | ( |
) | ( |
) | ||||||||||||||||||||||
Net income
|
— | — | ||||||||||||||||||||||||||
Balance as of September 30, 2022
|
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) |
For the Period from March 1, 2021 (inception) Through September 30, 2021 | ||||||||||||||||||||||||||||
Class A Common Stock
|
Class B Common Stock
|
Additional |
Total
|
|||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Paid-in
Capital
|
Accumulated
Deficit |
Stockholders’
Equity (Deficit)
|
||||||||||||||||||||||
Balance as of March 1, 2021
(inception)
|
|
$
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Issuance of Class B common stock to Sponsor(1)
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net loss
|
—
|
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Balance as of March 31, 2021
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||
Net loss
|
—
|
|
—
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
Balance as of June 30, 2021
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Excess of cash received over the fair value of the private placement warrants
|
— | — | ||||||||||||||||||||||||||
Excess of fair value of Founder Shares sold over the purchase price
|
— | — | ||||||||||||||||||||||||||
Excess of cash received over the fair value of the over-allotment private placement warrants
|
— | — | ||||||||||||||||||||||||||
Forfeiture of Class B common stock
|
( |
) | ( |
) | ||||||||||||||||||||||||
Accretion of Class A common stock to redemption amount
|
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Net income | — | — | ||||||||||||||||||||||||||
Balance as of September 30, 2021
|
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) |
For the Nine
Months Ended
September 30, 2022
|
For the Period from
March 1, 2021
(inception) Through
September 30, 2021
|
|||||||
Cash Flows from Operating Activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||||||
Realized gain on investments held in Trust Account
|
(
|
)
|
|
|||||
Unrealized gain on investments held in Trust Account
|
(
|
)
|
(
|
)
|
||||
Expensed offering costs
|
||||||||
Change in fair value of warrant liabilities
|
(
|
)
|
(
|
)
|
||||
Changes in operating assets and liabilities:
|
||||||||
Prepaid expenses
|
|
(
|
)
|
|||||
Accounts payable and accrued expenses
|
(
|
)
|
|
|||||
Franchise tax payable
|
(
|
)
|
|
|||||
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
Cash Flows from Investing Activities:
|
||||||||
Proceeds from redemption of U.S. government treasury obligations | ||||||||
Purchase of U.S. government treasury obligations
|
( |
) | ||||||
Investment of cash into Trust Account | ( |
) | ||||||
Net cash used in investing activities
|
( |
) | ||||||
Cash Flows from Financing Activities:
|
||||||||
Proceeds from promissory note - related party
|
|
|||||||
Repayment of promissory note - related party | ( |
) | ||||||
Proceeds from initial public offering, net of underwriting fees | ||||||||
Proceeds from sale of Private Placement Warrants | ||||||||
Payment of deferred offering costs
|
|
(
|
)
|
|||||
Proceeds from sale of Class B common stock to Sponsor
|
|
|
||||||
Net cash provided by financing activities
|
|
|
||||||
Net Change in Cash
|
(
|
)
|
|
|||||
Cash - Beginning of period
|
|
|
||||||
Cash - End of period
|
$
|
|
$
|
|
||||
Non-cash investing and financing activities
|
||||||||
Deferred underwriting fee payable | $ | $ | ||||||
Excess of the fair value of Founder Shares sold over the purchase price | $ | $ | ||||||
Forfeiture of Class B common stock | $ | $ | ||||||
Accretion of Class A common stock subject to redemption to redemption value | $ | $ | ||||||
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of September 30, 2022
|
$
|
|
$
|
|
||||
Deferred offering costs included in accrued offering costs
|
$
|
|
$
|
|
Gross proceeds
|
$
|
|
||
Less:
|
||||
Proceeds allocated to Public Warrants
|
(
|
)
|
||
Issuance costs allocated to Class A common stock
|
(
|
)
|
||
Plus:
|
||||
Initial accretion of carrying value to redemption value
|
|
|||
Subsequent accretion of carrying value to redemption value as of December 31, 2021
|
|
|||
Class A common stock subject to possible redemption as of December 31, 2021
|
|
|||
Subsequent accretion of carrying value to redemption value as of March 31, 2022
|
|
|||
Class A common stock subject to possible redemption as of March 31, 2022
|
|
|||
Subsequent accretion of carrying value to redemption value as of June 30, 2022
|
||||
Class A common stock subject to possible redemption as of June 30, 2022 | $ |
|||
Subsequent accretion of carrying value to redemption value as of September 30, 2022
|
||||
Class A common stock subject to possible redemption as of September 30, 2022 | $ |
For the three months
ended September 30, 2022
|
For the three months
ended September 30, 2021
|
For the nine months
ended September 30, 2022
|
For the Period from
March 1, 2021
(inception) Through
September 30, 2021
|
|||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Less: Accretion of Class A common stock to redemption amount
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net income (loss) including accretion of temporary equity to redemption value
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
For the Three Months
Ended September 30, 2022
|
For the Three Months
Ended September 30, 2021
|
For the Nine Months
Ended September 30, 2022
|
For the Period from
March 1, 2021
(inception) Through
September 30, 2021
|
|||||||||||||||||||||||||||||
Class A
|
Class B
|
Class A
|
Class B
|
Class A
|
Class B
|
Class A
|
Class B
|
|||||||||||||||||||||||||
Basic and diluted net income per share:
|
||||||||||||||||||||||||||||||||
Numerator:
|
||||||||||||||||||||||||||||||||
Net income (loss) including accretion of temporary equity to redemption value
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||
Accretion of Class A common stock to redemption amount
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Net income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
||||||||||||||
Denominator:
|
||||||||||||||||||||||||||||||||
Weighted Average Common Stock
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Basic and diluted net income (loss) per common share
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
• |
in whole and not in part;
|
• |
at a price of $
|
• |
upon not less than
|
• |
if, and only if, the last reported sale price of the Class A common stock for any
|
• |
in whole and not in part;
|
• |
at $
|
• |
if, and only if, the Reference Value equals or exceeds $
|
• |
if the Reference Value is less than $
|
September 30, 2022
|
December 31, 2021
|
|||||||
Deferred tax assets:
|
||||||||
Start-up costs
|
$
|
|
$
|
|
||||
Net operating loss carryforwards
|
|
|
||||||
Total deferred tax assets
|
|
|
||||||
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
Deferred tax liabilities:
|
||||||||
Unrealized gain on investments
|
(
|
)
|
(
|
)
|
||||
Total deferred tax liabilities
|
(
|
)
|
(
|
)
|
||||
Deferred tax assets, net of allowance
|
$
|
|
$
|
|
Federal
|
||||
Current
|
$
|
|
||
Deferred
|
(
|
)
|
||
State
|
||||
Current
|
$
|
|
||
Deferred
|
|
|||
Change in valuation allowance
|
|
|||
Income tax provision
|
$
|
|
September 30, 2022
|
December 31, 2021
|
|||||||
Statutory federal income tax rate
|
|
%
|
|
%
|
||||
State taxes, net of federal tax benefit
|
|
%
|
|
%
|
||||
Change in fair value of derivative warrant liabilities
|
(
|
)%
|
(
|
)%
|
||||
Non-deductible transaction costs
|
|
% |
|
%
|
||||
Change in valuation allowance
|
( |
)% |
|
%
|
||||
Income tax provision
|
|
%
|
|
%
|
Description
|
Amount at
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
September 30, 2022
|
||||||||||||||||
Assets
|
||||||||||||||||
Investments held in Trust Account:
|
||||||||||||||||
U.S. government treasury obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Liabilities
|
||||||||||||||||
Warrant liability – Public Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Warrant liability – Private Placement Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
Description
|
Amount at
Fair Value
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
December 31, 2021
|
||||||||||||||||
Assets
|
||||||||||||||||
Investments held in Trust Account:
|
||||||||||||||||
U.S. government treasury obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Liabilities
|
||||||||||||||||
Warrant liability – Public Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Warrant liability – Private Placement Warrants
|
$
|
|
$
|
|
$
|
|
$
|
|
As of July 30,
2021 (Initial
Measurement)
|
||||
Stock price
|
$
|
|
||
Exercise price
|
$
|
|
||
Dividend yield
|
|
% |
||
Expected term (in years)
|
|
|||
Volatility
|
|
%
|
||
Risk-free rate
|
|
%
|
||
Fair value
|
$
|
|
Fair value as of March 1, 2021
|
$
|
|
||
Initial measurement of Public Warrants and Private Placement Warrants as of July 30, 2021
|
|
|||
Initial measurement of Public Warrants and Private Placement Warrants upon exercise of over-allotment on August 20, 2021
|
|
|||
Transfer of Public Warrants to Level 1 measurement
|
(
|
)
|
||
Transfer of Private Placement Warrants to Level 2 measurement
|
(
|
)
|
||
Change in fair value
|
(
|
)
|
||
Fair value as of December 31, 2021
|
$
|
|
||
Change in fair value
|
|
|||
Fair value as of March 31, 2022
|
$
|
|
||
Change in fair value | ||||
Fair value as of June 30, 2022 | $ | |||
Change in fair value |
||||
Fair value as of September 30, 2022 |
$ |
As of July 30, 2021
(Initial
Measurement)
|
||||
Stock price
|
$
|
9.47
|
||
Exercise price
|
$
|
11.50
|
||
Dividend yield
|
—
|
%
|
||
Expected term (in years)
|
5.5
|
|||
Volatility
|
20.0
|
%
|
||
Risk-free rate
|
0.80
|
%
|
||
Fair value
|
$
|
0.95
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk.
|
ITEM 1. |
LEGAL PROCEEDINGS
|
ITEM 1A. |
RISK FACTORS
|
ITEM 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
ITEM 3. |
DEFAULTS UPON SENIOR SECURITIES
|
ITEM 4. |
MINE SAFETY DISCLOSURES
|
ITEM 5. |
OTHER INFORMATION
|
ITEM 6. |
EXHIBITS
|
Exhibit No.
|
Description
|
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
101.INS*
|
XBRL Instance Document
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB*
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
Filed herewith.
|
**
|
Furnished.
|
Mercury Ecommerce Acquisition Corp.
|
||
Date: November 10, 2022
|
By:
|
/s/ Andrew White
|
Name: Andrew White
|
||
Title: Chief Executive Officer
|
Mercury Ecommerce Acquisition Corp.
|
||
Date: November 10, 2022
|
By:
|
/s/ Winston Gilpin
|
Name: Winston Gilpin
|
||
Title: Chief Financial Officer
|